Van de Vijver MJ - Search Results

1

The diagnosis and management of pre-invasive breast disease: pathological diagnosis--problems with existing classifications.

Van de Vijver MJ, Peterse H. Van de Vijver MJ, et al. Breast Cancer Res. 2003;5(5):269. doi: 10.1186/bcr629. Epub 2003 Jul 29. Breast Cancer Res. 2003. PMID: 12927038 Free PMC article. Review.

2

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, et al. Schuuring E, et al. Among authors: van de vijver mj, van tinteren h. Cancer Res. 1992 Oct 1;52(19):5229-34. Cancer Res. 1992. PMID: 1394126

3

Ductal carcinoma in situ of the breast: histological classification and genetic alterations.

van de Vijver MJ. van de Vijver MJ. Recent Results Cancer Res. 1998;152:123-34. doi: 10.1007/978-3-642-45769-2_11. Recent Results Cancer Res. 1998. PMID: 9928552 Review.

4

Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).

van de Vijver MJ. van de Vijver MJ. Eur J Cancer. 2001 Jan;37 Suppl 1:S11-7. Eur J Cancer. 2001. PMID: 11167086 Review.

5

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.

Bijker N, Peterse JL, Duchateau L, Robanus-Maandag EC, Bosch CA, Duval C, Pilotti S, van de Vijver MJ. Bijker N, et al. Among authors: van de vijver mj. Br J Cancer. 2001 Feb;84(4):539-44. doi: 10.1054/bjoc.2000.1618. Br J Cancer. 2001. PMID: 11207051 Free PMC article. Clinical Trial.

6

The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era: historical perspectives.

van de Vijver MJ. van de Vijver MJ. Breast Cancer Res. 1999;1(1):27-30. doi: 10.1186/bcr9. Epub 1999 Oct 27. Breast Cancer Res. 1999. PMID: 11250679 Free PMC article. Review.

7

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ. Bijker N, et al. Among authors: van de vijver mj, de mascarel i. J Clin Oncol. 2001 Apr 15;19(8):2263-71. doi: 10.1200/JCO.2001.19.8.2263. J Clin Oncol. 2001. PMID: 11304780 Clinical Trial.

8

Gene expression profiling predicts clinical outcome of breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. van 't Veer LJ, et al. Among authors: van der kooy k, van de vijver mj. Nature. 2002 Jan 31;415(6871):530-6. doi: 10.1038/415530a. Nature. 2002. PMID: 11823860

9

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.

Faneyte IF, Schrama JG, Peterse JL, Remijnse PL, Rodenhuis S, van de Vijver MJ. Faneyte IF, et al. Among authors: van de vijver mj. Br J Cancer. 2003 Feb 10;88(3):406-12. doi: 10.1038/sj.bjc.6600749. Br J Cancer. 2003. PMID: 12569384 Free PMC article.

10

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

Robanus-Maandag EC, Bosch CA, Kristel PM, Hart AA, Faneyte IF, Nederlof PM, Peterse JL, van de Vijver MJ. Robanus-Maandag EC, et al. Among authors: van de vijver mj. J Pathol. 2003 Sep;201(1):75-82. doi: 10.1002/path.1385. J Pathol. 2003. PMID: 12950019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page